Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc.

Nature of the Filing

The provided text is a letter from Rocket Pharmaceuticals, Inc.’s counsel to Judge P. Kevin Castel. Rocket asked for permission to file certain materials under seal and to redact portions of its letter requesting the disqualification of Dr. Peluso. The text does not include a court order or state that Judge Castel granted or denied any request.

Materials Rocket Sought to Seal or Redact

Rocket requested that Exhibit 1 to the declaration supporting its disqualification request be sealed in full. The exhibit is described as a consulting agreement between Renovacor and Dr. Peluso containing terms about consulting services and Dr. Peluso’s consulting rate.

Rocket also requested that Exhibit 4 be sealed in full. It is described as part of a Renovacor document showing Scientific Advisory Board members’ meeting attendance and payments. Rocket further requested that Exhibit 5 be sealed in full. It is described as a confidential presentation concerning Renovacor’s business strategy and technical information from Rocket and Renovacor.

Rocket asked to redact and partially seal sections of its disqualification request that quoted or discussed the same materials.

Reasons Given for Sealing

Rocket argued that sealing was necessary to protect confidential business information and trade secrets. It asserted that disclosure could harm Rocket’s commercial standing and could reveal commercially sensitive information, including payment information, meeting information, business strategy, and technical information.

Disposition

The provided text does not show a ruling by Judge Castel. It therefore does not establish whether the request to seal, the requested redactions, or the request to disqualify Dr. Peluso was granted, denied, or otherwise resolved.